BACE1-AS has been shown to upregulate BACE1 expression in AD subjects [211], and BACE1-AS itself has been shown to be highly expressed in the blood and brain of AD patients and in AD animal models, thus facilitating AD progression via its effects on BACE1 activity. Here, BACE1 is linked to Alzheimer disease.